Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,43 € ↓ -0,01 (-0,01%)
2026-06-04
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionBoyar Asset Management Inc.
Latest Disclosed Ownership16,532 shares
Latest Disclosed Value $ 1,002,689
Boyar Asset Management Inc. reports 0.22% decrease in ownership of BRM / Bristol-Myers Squibb Company

On May 8, 2026 - Boyar Asset Management Inc. filed a 13F-HR form disclosing ownership of 16,532 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $866,607 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 16,569 shares of Bristol-Myers Squibb Company. This represents a change in shares of -0.22% during the quarter. The current value of the position is $784,113 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 16,532 -37 -0.22 1,003 12.21 0.5706
2026-02-13 2025-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 16,569 -150 -0.90 894 18.44 0.5667
2025-11-18 2025-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 16,719 -6,446 -27.83 754 -29.66 0.4771
2025-07-21 2025-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 23,165 -1,828 -7.31 1,072 -29.66 0.7017
2025-04-23 2025-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 24,993 -5,075 -16.88 1,524 -10.35 1.1056
2025-02-14 2024-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 30,068 1 0.00 1,701 9.32 1.1219
2024-11-22 2024-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 30,067 2 0.01 1,556 24.60 1.0016
2024-08-05 2024-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 30,065 -351 -1.15 1,249 -24.32 0.8566
2024-05-06 2024-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 30,416 1,309 4.50 1,649 10.45 1.0758
2024-02-14 2023-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 29,107 -2,108 -6.75 1,494 -17.56 1.1209
2023-11-08 2023-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 31,215 -350 -1.11 1,812 -10.26 1.4225
2023-07-27 2023-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 31,565 -133 -0.42 2,019 -8.11 1.4934
2023-04-27 2023-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 31,698 371 1.18 2,197 -2.53 1.6946
2023-02-10 2022-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 31,327 -399 -1.26 2,254 -0.09 1.8379
2022-11-08 2022-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 31,726 -49 -0.15 2,255 -7.85 1.8572
2022-08-08 2022-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 31,775 -3,126 -8.96 2,447 -4.00 2.0198
2022-04-27 2022-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 34,901 216 0.62 2,549 17.85 1.6371
2022-02-10 2021-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 34,685 -100 -0.29 2,163 5.10 1.3032
2021-10-18 2021-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 34,785 -83 -0.24 2,058 -11.67 1.3556
2021-08-04 2021-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 34,868 1 0.00 2,330 5.86 1.5010
2021-05-04 2021-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 34,867 -303 -0.86 2,201 0.87 1.4884
2021-02-10 2020-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 35,170 -2,769 -7.30 2,182 -4.59 1.6453
2020-11-09 2020-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 37,939 715 1.92 2,287 4.48 1.9204
2020-07-31 2020-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 37,224 0 0.00 2,189 5.49 2.0262
2020-04-17 2020-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 37,224 -499 -1.32 2,075 -14.29 2.3232
2020-02-13 2019-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 37,723 -707 -1.84 2,421 24.22 1.7486
2019-11-13 2019-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 38,430 -700 -1.79 1,949 9.80 1.4791
2019-08-06 2019-06-30 13F BRISTOL MYERS SQUIBB COM 110122108 39,130 -303 -0.77 1,775 -5.64 1.3110
2019-05-01 2019-03-31 13F BRISTOL MYERS SQUIBB COM 110122108 39,433 0 0.00 1,881 -8.24 1.4145
2019-02-13 2018-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 39,433 -735 -1.83 2,050 -17.80 1.6889
2018-11-06 2018-09-30 13F Bristol-Myers Squibb CS 110122108 40,168 0 0.00 2,494 12.19 1.6986
2018-08-14 2018-06-30 13F Bristol-Myers Squibb CS 110122108 40,168 0 0.00 2,223 -12.51 1.6346
2018-05-15 2018-03-31 13F Bristol-Myers Squibb CS 110122108 40,168 -247 -0.61 2,541 2.58 1.8473
2018-02-14 2017-12-31 13F Bristol-Myers Squibb CS 110122108 40,415 158 0.39 2,477 -3.47 1.7623
2017-11-02 2017-09-30 13F Bristol-Myers Squibb CS 110122108 40,257 0 0.00 2,566 14.40 1.9166
2017-08-09 2017-06-30 13F Bristol-Myers Squibb CS 110122108 40,257 -837 -2.04 2,243 0.36 1.6484
2017-05-15 2017-03-31 13F Bristol-Myers Squibb CS 110122108 41,094 8,584 26.40 2,235 17.63 1.6446
2017-02-08 2016-12-31 13F Bristol-Myers Squibb CS 110122108 32,510 -8,695 -21.10 1,900 -14.49 1.9015
2016-11-02 2016-09-30 13F Bristol-Myers Squibb CS 110122108 41,205 -674 -1.61 2,222 -27.86 1.7540
2016-08-12 2016-06-30 13F Bristol-Myers Squibb CS 110122108 41,879 -600 -1.41 3,080 13.49 2.4425
2016-05-06 2016-03-31 13F Bristol-Myers Squibb CS 110122108 42,479 -300 -0.70 2,714 -7.78 2.1300
2016-02-02 2015-12-31 13F Bristol-Myers Squibb CS 110122108 42,779 -100 -0.23 2,943 15.96 2.3402
2015-11-13 2015-09-30 13F Bristol-Myers Squibb CS 110122108 42,879 -550 -1.27 2,538 -12.18 2.1590
2015-08-10 2015-06-30 13F Bristol-Myers Squibb CS 110122108 43,429 -400 -0.91 2,890 2.23 2.2108
2015-05-01 2015-03-31 13F Bristol-Myers Squibb COM 110122108 43,829 -7,729 -14.99 2,827 -7.10 2.1633
2015-02-12 2014-12-31 13F Bristol-Myers Squibb COM 110122108 51,558 -1,900 -3.55 3,043 11.22 2.3790
2014-11-06 2014-09-30 13F Bristol-Myers Squibb COM 110122108 53,458 -1,600 -2.91 2,736 2.43 2.1111
2014-07-28 2014-06-30 13F Bristol-Myers Squibb Common Stock 110122108 55,058 -3,500 -5.98 2,671 -12.20 2.1233
2014-05-09 2014-03-31 13F Bristol-Myers Squibb CS 110122108 58,558 -1,401 -2.34 3,042 -4.55 2.4796
2014-02-04 2013-12-31 13F Bristol-Myers Squibb COM 110122108 59,959 1,000 1.70 3,187 16.78 2.6470
2013-11-12 2013-09-30 13F Bristol-Myers Squibb COM 110122108 58,959 -638 -1.07 2,729 2.48 2.6154
2013-08-09 2013-06-30 13F Bristol-Myers Squibb COM 110122108 59,597 59,597 2,663 2.6548
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.